Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea

AstraZeneca4,950 enrolled

Overview

This is a multi-centre, cross-sectional, chart review study to investigate cholesterol goal attainment rates defined by modified NCEP-ATP III guidelines and define its possible determinants among Korean dyslipidemic patients

MC MD

Study Type

OBSERVATIONAL

Enrollment

4,950

Conditions

Dyslipidemia

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient who has a dyslipidemia with a lipid profile result within 3 months * Patient who has a dyslipidemia without change of lipid lowering drug dosage during 3 months after lipid profile test. Exclusion Criteria: * Patient who involved in this study previously. * Patient who participated in other clinical study with study drug within 90 days.

Locations (20)

Research Site

Busan, Busan, South Korea

Research Site

Cheonan, Chungcheongnam-do, South Korea

Outcomes

Primary Outcomes

Cholesterol goal attainment rate according to NCEP-ATP III guideline

Time frame: Once, at enrollment

Secondary Outcomes

Factors for cholesterol goal achievement: Age, Family history, smoking history, waist circumstance, etc.

Time frame: Once, at enrollment

Cholesterol goal attainment rate related to CHD or disease history

Time frame: Once, at enrollment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.